Ultrasound + ctDNA
Ultrasound + ctDNA has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, Jan 28, 2026: “Integration of ultrasonography and circulating tumor DNA analysis enhances early detection of asymptomatic ovarian cancer”.
1 paper studies it1 findingUpdated
See all 1 papers on ultrasound + ctDNA
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“The combined diagnostic approach significantly improved detection parameters (p < 0.001), with sensitivity increasing to 93.75%, specificity to 99.25%, PPV to 75.00%, and NPV to 99.85%.”
- 1 lab in 1 country
- Humans1
What did studies of ultrasound + ctDNA find?
1Studies of ultrasound + ctDNA measured one outcome, early detection of asymptomatic ovarian cancer.
Early detection of asymptomatic ovarian cancer
upin humans1
1 study
Early detection of asymptomatic ovarian cancer
upin humans1
Ultrasound + ctDNA is linked with better early detection of asymptomatic ovarian cancer in humans (asymptomatic ovarian cancer) (p < 0.001, sensitivity 93.75%, specificity 99.25%).
“The combined diagnostic approach significantly improved detection parameters (p < 0.001), with sensitivity increasing to 93.75%, specificity to 99.25%, PPV to 75.00%, and NPV to 99.85%.”
Humansasymptomatic ovarian cancern = 686
Ginekologia polska